162 related articles for article (PubMed ID: 20074590)
1. Angiotensin-(1-7) prevents atrial fibrosis and atrial fibrillation in long-term atrial tachycardia dogs.
Liu E; Yang S; Xu Z; Li J; Yang W; Li G
Regul Pept; 2010 Jun; 162(1-3):73-8. PubMed ID: 20074590
[TBL] [Abstract][Full Text] [Related]
2. The potential role of atrial natriuretic peptide in the effects of Angiotensin-(1-7) in a chronic atrial tachycardia canine model.
Zhao J; Liu T; Liu E; Li G; Qi L; Li J
J Renin Angiotensin Aldosterone Syst; 2016; 17(1):1470320315627409. PubMed ID: 27009283
[TBL] [Abstract][Full Text] [Related]
3. Enalapril, irbesartan, and angiotensin-(1-7) prevent atrial tachycardia-induced ionic remodeling.
Liu E; Xu Z; Li J; Yang S; Yang W; Li G
Int J Cardiol; 2011 Feb; 146(3):364-70. PubMed ID: 19732978
[TBL] [Abstract][Full Text] [Related]
4. Effects of the angiotensin-(1-7)/Mas/PI3K/Akt/nitric oxide axis and the possible role of atrial natriuretic peptide in an acute atrial tachycardia canine model.
Zhao J; Liu E; Li G; Qi L; Li J; Yang W
J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):1069-77. PubMed ID: 25143331
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin-(1-7) attenuates atrial tachycardia-induced sympathetic nerve remodeling.
Shangguan W; Shi W; Li G; Wang Y; Li J; Wang X
J Renin Angiotensin Aldosterone Syst; 2017; 18(3):1470320317729281. PubMed ID: 28877652
[TBL] [Abstract][Full Text] [Related]
6. The effects of cilazapril and valsartan on the mRNA and protein expressions of atrial calpains and atrial structural remodeling in atrial fibrillation dogs.
Li Y; Li WM; Gong YT; Li BX; Liu W; Han W; Dong D; Sheng L; Xue JY; Zhang L; Chu S; Yang BF
Basic Res Cardiol; 2007 May; 102(3):245-56. PubMed ID: 17268887
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-(1-7) prevent atrial tachycardia induced sodium channel remodeling.
Wang X; Li G
Pacing Clin Electrophysiol; 2014 Oct; 37(10):1349-56. PubMed ID: 24861429
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of angiotensin converting enzyme II is associated with pacing-induced sustained atrial fibrillation.
Pan CH; Lin JL; Lai LP; Chen CL; Stephen Huang SK; Lin CS
FEBS Lett; 2007 Feb; 581(3):526-34. PubMed ID: 17254576
[TBL] [Abstract][Full Text] [Related]
9. Effects of Cilazapril on atrial electrical, structural and functional remodeling in atrial fibrillation dogs.
Li Y; Li W; Yang B; Han W; Dong D; Xue J; Li B; Yang S; Sheng L
J Electrocardiol; 2007 Jan; 40(1):100.e1-6. PubMed ID: 17067622
[TBL] [Abstract][Full Text] [Related]
10. Effects of chronic gap junction conduction-enhancing antiarrhythmic peptide GAP-134 administration on experimental atrial fibrillation in dogs.
Laurent G; Leong-Poi H; Mangat I; Moe GW; Hu X; So PP; Tarulli E; Ramadeen A; Rossman EI; Hennan JK; Dorian P
Circ Arrhythm Electrophysiol; 2009 Apr; 2(2):171-8. PubMed ID: 19808462
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin-(1-7) prevents atrial tachycardia induced-heat shock protein 27 expression.
Wang X; Shangguan W; Li G
J Electrocardiol; 2018; 51(1):117-120. PubMed ID: 29056233
[TBL] [Abstract][Full Text] [Related]
12. Effects of spironolactone on electrical and structural remodeling of atrium in congestive heart failure dogs.
Yang SS; Han W; Zhou HY; Dong G; Wang BC; Huo H; Wei N; Cao Y; Zhou G; Xiu CH; Li WM
Chin Med J (Engl); 2008 Jan; 121(1):38-42. PubMed ID: 18208664
[TBL] [Abstract][Full Text] [Related]
13. Suppression of experimental atrial fibrillation in a canine model of rapid atrial pacing by the phosphodiesterase 3 inhibitor cilostazol.
Zhao Z; Li R; Wang X; Li J; Xu X; Liu T; Liu E; Li G
J Electrocardiol; 2020; 60():151-158. PubMed ID: 32371198
[TBL] [Abstract][Full Text] [Related]
14. Effect of irbesartan on development of atrial fibrosis and atrial fibrillation in a canine atrial tachycardia model with left ventricular dysfunction, association with p53.
Kataoka N; Nishida K; Kinoshita K; Sakamoto T; Nakatani Y; Tsujino Y; Mizumaki K; Inoue H; Kinugawa K
Heart Vessels; 2016 Dec; 31(12):2053-2060. PubMed ID: 27236656
[TBL] [Abstract][Full Text] [Related]
15. Atrial and ventricular fibrosis induced by atrial fibrillation: evidence to support early rhythm control.
Avitall B; Bi J; Mykytsey A; Chicos A
Heart Rhythm; 2008 Jun; 5(6):839-45. PubMed ID: 18534368
[TBL] [Abstract][Full Text] [Related]
16. Linear lesions provide protection from atrial fibrillation induction with rapid atrial pacing.
Avitall B; Urbonas A; Urboniene D; Rozmus G; Helms R
J Cardiovasc Electrophysiol; 2002 May; 13(5):455-62. PubMed ID: 12030527
[TBL] [Abstract][Full Text] [Related]
17. Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort.
Li D; Fareh S; Leung TK; Nattel S
Circulation; 1999 Jul; 100(1):87-95. PubMed ID: 10393686
[TBL] [Abstract][Full Text] [Related]
18. Cilostazol Prevents Atrial Structural Remodeling through the MEK/ERK Pathway in a Canine Model of Atrial Tachycardia.
Zhao Z; Wang Y; Chen Y; Wang X; Li J; Yuan M; Liu T; Li G
Cardiology; 2016; 135(4):240-248. PubMed ID: 27532517
[TBL] [Abstract][Full Text] [Related]
19. Losartan affects the substrate for atrial fibrillation maintenance in a rabbit model.
Zhao Y; Gu TX; Zhang GW; Liu HG; Wang C
Cardiovasc Pathol; 2013; 22(5):383-8. PubMed ID: 23528876
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin-converting enzyme-2 overexpression improves atrial remodeling and function in a canine model of atrial fibrillation.
Zhou T; Wang Z; Fan J; Chen S; Tan Z; Yang H; Yin Y
J Am Heart Assoc; 2015 Mar; 4(3):e001530. PubMed ID: 25792125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
